# Safety of Remifentanil Infusion

> **NCT01303627** · PHASE4 · COMPLETED · sponsor: **Diskapi Teaching and Research Hospital** · enrollment: 42 (actual)

## Conditions studied

- Urinary Tract Problem

## Interventions

- **DRUG:** remifentanil

## Key facts

- **NCT ID:** NCT01303627
- **Lead sponsor:** Diskapi Teaching and Research Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-02
- **Primary completion:** 2011-03
- **Final completion:** 2011-04
- **Target enrollment:** 42 (ACTUAL)
- **Last updated:** 2012-06-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01303627

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01303627, "Safety of Remifentanil Infusion". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT01303627. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*